Clinical Trial: The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07244770) titled 'The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients' on Jan. 09.

Brief Summary: The study aims to investigate the effects of DPP-4 Is+ metformin versus SGLT2 Is + metformin on the risk of cognitive decline and depression in patients with T2DM.

Study Start Date: Jan. 01

Study Type: OBSERVATIONAL

Condition: MCI

Intervention: DRUG: SGLT2 Is+METFORMIN

Patients administering SGLT2 Is+metformin added to their treatment for at least the past 12 months

DRUG: DPP4 Is+metformin

Patients administering DPP4 I+ metformin added to their treatment for at least the past 12 months

D...